Skip to content
Search AI Powered

Latest Stories

Pregabalin capsules included in second drug price concessions list for March

The Department of Health and Social Care (DH) has included following list of drugs in its second drug price concessions list released for March 2021.

DrugPack SizePrice Concession
Duloxetine 20mg gastro-resistant capsules28£7.75
Eplerenone 50mg tablets28£25.49
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets28£15.93
Pregabalin 200mg capsules84£7.79
Pregabalin 50mg capsules84£5.11
Pregabalin 75mg capsules56£5.32
Ropinirole 1mg tablets84£25.99
Trimethoprim 50mg/5ml oral suspension sugar free100ml£9.99
Zonisamide 100mg capsules56£54.80

Previous drug price concessions list released on March 19.


DrugPack SizePrice Concession
Chlorpromazine 50mg tablets28£19.95
Ciprofloxacin 500mg tablets10£3.11
Duloxetine 30mg gastro-resistant capsules28£1.82
Duloxetine 60mg gastro-resistant capsules28£3.18
Enalapril 10mg tablets28£5.99
Eplerenone 25mg tablets28£12.35
Esomeprazole 20mg gastro-resistant capsules28£3.67
Esomeprazole 20mg gastro-resistant tablets28£5.80
Esomeprazole 40mg gastro-resistant capsules28£3.85
Lamotrigine 100mg tablets56£5.90
Lamotrigine 25mg tablets56£2.30
Lamotrigine 50mg tablets56£4.50
Letrozole 2.5mg tablets14£2.25
Moxonidine 200microgram tablets28£9.59
Moxonidine 300microgram tablets28£5.95
Moxonidine 400microgram tablets28£7.00
Olmesartan medoxomil 10mg tablets28£9.95
Olmesartan medoxomil 20mg tablets28£12.29
Olmesartan medoxomil 40mg tablets28£15.95
Pregabalin 100mg capsules84£6.88
Pregabalin 25mg capsules56£2.15
Tamoxifen 20mg tablets30£8.20
Topiramate 25mg capsules60£22.18

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less